Über das Unternehmen

Anaeropharma Science was established in 2004 to pioneer the development of novel therapeutics to target such a hypoxic environment in solid cancers based on its proprietary platform technology, recombinant bifidobacterium therapeutics.

JP
Unbekannt
Nicht verifiziertes Unternehmen